[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 7, Issue 1 (Spring 2010) ::
Sci J Iran Blood Transfus Organ 2010, 7(1): 48-54 Back to browse issues page
Re-evaluation of potency of IBRF-manufactured anti-A and anti-B blood grouping reagents against the new WHO international minimum potency standards
A. Talebian , A.R. Shafaei, M. Sharafi, S. Rivandi, L. Jalili, T. Fattaheian
Abstract:   (13584 Views)

 

 

  Abstract

 Background and Objectives

 ABO blood group system antibodies agglutinate red blood cell suspension in physiologic serum directly without any reaction booster. In the present study the potency of IBRF-manufactured anti-A and anti-B blood grouping reagents by the hemagglutination method in test tube was reassessed against the new WHO international minimum potency standards.

 

 Materials and Methods

 In this experimental study, starting concentrations defined in WHO standards were used in titration. Doubled dilution series of WHO standards (from starting concentrations) and IBRF blood grouping reagents (from neat) were prepared by using buffered saline containing 2% BSA as diluent. One volume of each starting concentration together with one volume of prepared dilutions were mixed with one volume of a 2% suspension of A1, A2, A2B, and B cells in glass test tubes, respectively. After appropriate incubation and centrifugation of the tests according to specified criteria, the reactions were graded macroscopically.

 

  Results

 The results showed that the IBRF anti-A and anti-B blood grouping reagents comply with the minimum WHO standard dilution. Consequently, IBRF anti-A and anti-B blood grouping reagents were shown to be safe for screening and diagnostic purposes.

 

 Conclusions

 The quality of blood grouping reagents is clearly an important factor for safe blood transfusion. Routine titration tests are not reliable methods for evaluation of those reagents. Fortunately, this problem would be solved using the above standards. This recommended method is provided to help assist manufacturers in pursuing new product license applications and making amendments in existing ones. 

  

 Key words : Reagents, Agglutination, Standards

 

Keywords: Reagents, Agglutination, Standards
Full-Text [PDF 204 kb]   (5694 Downloads)    
Type of Study: Research | Subject: Hematology
Published: 2014/07/23
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Talebian A, Shafaei A, Sharafi M, Rivandi S, Jalili L, Fattaheian T. Re-evaluation of potency of IBRF-manufactured anti-A and anti-B blood grouping reagents against the new WHO international minimum potency standards . Sci J Iran Blood Transfus Organ. 2010; 7 (1) :48-54
URL: http://bloodjournal.ir/article-1-384-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 1 (Spring 2010) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4341